Our data showed that, during the in vivo growth, tumor upregulates β3-AR, and its antagonism is extraordinarily effective in reducing stemness in the TME, highlighting the crucial role played by β3-ARs in favoring tumor progression. Here, ADRB3 is linked to neoplasm.